What are the key changes in director compensation?

The 2019 compensation program for HCA's non-management directors includes an annual cash retainer of $110,000, with additional retainers for committee service and chair positions. They will also receive an annual equity award valued at $175,000, consisting of restricted stock units that vest on the earlier of the next annual meeting or the first anniversary of the grant date, subject to continued service.

What is the impact of eliminating supermajority voting requirements?

The elimination of supermajority voting requirements from the company's Certificate of Incorporation and Bylaws means that corporate decisions will now require a simple majority vote, rather than a higher threshold (e.g., two-thirds). This change is intended to streamline the decision-making process and make it easier to pass proposals.

Are there any new stock ownership requirements for directors?

Yes, non-management directors are now expected to acquire HCA common stock, directly or indirectly, with a value equivalent to five times their annual cash retainer for board service within five years of their election to the board.

What were the major outcomes of the Annual Meeting of Stockholders?

At the April 26, 2019 Annual Meeting, shareholders elected all eleven director nominees, ratified Ernst & Young LLP as the independent auditor for 2019, approved advisory compensation for named executive officers, and voted in favor of amending the company's charter and bylaws to remove supermajority voting requirements.

HCA 8-K: Leadership Changes, Shareholder Matters & More

Summary

HCA Healthcare, Inc. (HCA) filed an 8-K on May 1, 2019, reporting key corporate governance and shareholder voting outcomes from its Annual Meeting held on April 26, 2019. The most significant information for investors pertains to changes in director compensation and amendments to the company's charter and bylaws. Key financial decisions include the approval of the 2019 Board of Directors compensation program, which introduces new cash retainers and annual equity awards for non-management directors, with specific requirements for stock ownership. Additionally, HCA shareholders approved amendments to the company's Amended and Restated Certificate of Incorporation and Bylaws to eliminate supermajority voting requirements, a move that simplifies decision-making processes. The filing also confirms the election of eleven director nominees and the ratification of Ernst & Young LLP as the independent auditor.

Key Highlights

1HCA Healthcare updated its 2019 Board of Directors compensation program, introducing cash retainers and annual equity awards for non-management directors.
2Non-management directors will receive a $110,000 annual retainer, with additional amounts for committee service, and an annual equity award valued at $175,000, vesting on the anniversary of the grant.
3New stock ownership guidelines require non-management directors to acquire shares valued at five times their annual cash retainer within five years.
4Shareholders approved amendments to the company's Certificate of Incorporation and Bylaws to eliminate supermajority voting requirements, effective May 1, 2019.
5All eleven director nominees presented at the Annual Meeting were elected to the Board of Directors.
6Ernst & Young LLP was ratified as the independent registered public accounting firm for the fiscal year ending December 31, 2019.
7A non-binding advisory resolution on executive compensation was approved by shareholders.

HCA Healthcare, Inc. 8-K Report, Executive Changes (May 2, 2019)

Summary

Key Highlights

Frequently Asked Questions